The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.

Eli Lilly and Company

AbbVie Inc.

Merck & Co., Inc.

Johnson & Johnson

Bristol-Myers Squibb Company

Viatris Inc.

Biogen Inc.

Cardinal Health, Inc.

Pfizer Inc.

Vertex Pharmaceuticals Incorporated

Healthcare

First Trust Nasdaq Pharmaceuticals ETF

FTXH Holdings & Sector Breakdown

FTXH Holdings & Sector Breakdown